share_log

Teachers Retirement System of The State of Kentucky Decreases Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Teachers Retirement System of The State of Kentucky Decreases Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

肯塔基州教师退休制度减少了西部制药服务公司(纽约证券交易所代码:WST)的股票头寸
Defense World ·  2022/09/21 06:31

Teachers Retirement System of The State of Kentucky lessened its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 4.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 5,271 shares of the medical instruments supplier's stock after selling 229 shares during the period. Teachers Retirement System of The State of Kentucky's holdings in West Pharmaceutical Services were worth $2,165,000 at the end of the most recent quarter.

肯塔基州教师退休系统公司最近向美国证券交易委员会提交的13F文件显示,今年第一季度,该公司减持了West Pharmtics Services,Inc.的股票4.2%。该公司在此期间出售了229股后,拥有这家医疗器械供应商的5271股股票。肯塔基州教师退休制度在最近一个季度末,肯塔基州在West Pharmtics Services持有的股份价值2,165,000美元。

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in West Pharmaceutical Services by 1.0% in the first quarter. Vanguard Group Inc. now owns 8,716,312 shares of the medical instruments supplier's stock worth $3,579,876,000 after purchasing an additional 82,459 shares during the period. BlackRock Inc. increased its stake in West Pharmaceutical Services by 8.9% in the fourth quarter. BlackRock Inc. now owns 8,094,288 shares of the medical instruments supplier's stock worth $3,796,302,000 after purchasing an additional 664,275 shares during the period. State Street Corp increased its stake in West Pharmaceutical Services by 1.6% in the fourth quarter. State Street Corp now owns 3,455,709 shares of the medical instruments supplier's stock worth $1,620,762,000 after purchasing an additional 54,510 shares during the period. WCM Investment Management LLC increased its stake in West Pharmaceutical Services by 0.8% in the first quarter. WCM Investment Management LLC now owns 1,526,481 shares of the medical instruments supplier's stock worth $626,941,000 after purchasing an additional 11,655 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its stake in West Pharmaceutical Services by 1.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 741,881 shares of the medical instruments supplier's stock worth $304,698,000 after purchasing an additional 11,569 shares during the period. Hedge funds and other institutional investors own 91.98% of the company's stock.

其他几家对冲基金和其他机构投资者最近也买卖了该股的股票。先锋集团(Vanguard Group Inc.)在第一季度增持了西部医药服务公司1.0%的股份。先锋集团现在持有这家医疗器械供应商的8,716,312股股票,价值3,579,876,000美元,在此期间又购买了82,459股。贝莱德股份有限公司在第四季度增持了西部药业8.9%的股份。贝莱德股份有限公司在此期间增持了664,275股,目前持有这家医疗器械供应商8,094,288股股票,价值3,796,302,000美元。道富集团第四季度增持西部医药服务公司1.6%的股份。道富集团目前持有这家医疗器械供应商3,455,709股股票,价值1,620,762,000美元,在此期间又购买了54,510股。WCM Investment Management LLC在第一季度增持了西方医药服务公司0.8%的股份。WCM Investment Management LLC现在拥有这家医疗器械供应商1,526,481股股票,价值626,941,000美元,在此期间又购买了11,655股。最后,马萨诸塞州金融服务公司在第一季度增持了西部药业1.6%的股份。马云目前持有这家医疗器械供应商741,881股股票,价值304,698,000美元。在此期间,马云又购买了11,569股。对冲基金和其他机构投资者持有该公司91.98%的股票。

Get
到达
West Pharmaceutical Services
西部药业服务公司
alerts:
警报:

Insider Activity

内幕活动

In other news, insider Silji Abraham sold 5,374 shares of the firm's stock in a transaction on Monday, August 1st. The stock was sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the transaction, the insider now owns 3,201 shares in the company, valued at $1,100,919.93. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.60% of the company's stock.

在其他新闻方面,内部人士Silji Abraham在8月1日星期一的一笔交易中出售了5374股该公司股票。股票以343.93美元的平均价格出售,总成交金额为1,848,279.82美元。交易完成后,这位内部人士现在拥有该公司3201股,价值1100,919.93美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,该文件可通过这个环节。内部人士持有该公司0.60%的股份。

West Pharmaceutical Services Stock Performance

西部医药服务公司股票表现

WST stock opened at $263.69 on Wednesday. The company has a quick ratio of 2.41, a current ratio of 3.13 and a debt-to-equity ratio of 0.09. The business's fifty day simple moving average is $311.87 and its two-hundred day simple moving average is $329.79. West Pharmaceutical Services, Inc. has a twelve month low of $261.31 and a twelve month high of $475.00. The firm has a market cap of $19.53 billion, a price-to-earnings ratio of 29.27, a PEG ratio of 1.09 and a beta of 1.18.
周三,WST股价开盘报263.69美元。该公司的速动比率为2.41,流动比率为3.13,债务权益比为0.09。该业务的50日简单移动均线切入位为311.87美元,200日简单移动均线切入位为329.79美元。West Pharmtics Services,Inc.的12个月低点为261.31美元,12个月高位为475.00美元。该公司市值为195.3亿美元,市盈率为29.27倍,聚乙二醇率为1.09倍,贝塔系数为1.18。

West Pharmaceutical Services (NYSE:WST – Get Rating) last released its earnings results on Thursday, July 28th. The medical instruments supplier reported $2.47 earnings per share for the quarter, topping analysts' consensus estimates of $2.19 by $0.28. The business had revenue of $771.30 million for the quarter, compared to analyst estimates of $754.25 million. West Pharmaceutical Services had a return on equity of 29.08% and a net margin of 23.41%. The business's revenue was up 6.6% compared to the same quarter last year. During the same quarter last year, the firm posted $2.46 earnings per share. Analysts predict that West Pharmaceutical Services, Inc. will post 9.09 earnings per share for the current year.

West Pharmtics Services(纽约证券交易所代码:WST-GET Rating)最近一次公布收益结果是在7月28日星期四。这家医疗器械供应商公布本季度每股收益为2.47美元,比分析师普遍预期的2.19美元高出0.28美元。该业务本季度营收为7.713亿美元,而分析师预期为7.5425亿美元。西部医药服务公司的股本回报率为29.08%,净利润率为23.41%。与去年同期相比,该业务的收入增长了6.6%。去年同一季度,该公司公布的每股收益为2.46美元。分析人士预计,西部医药服务公司本年度每股收益将达到9.09美元。

West Pharmaceutical Services Company Profile

西部医药服务公司简介

(Get Rating)

(获取评级)

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

西方制药服务公司在美洲、欧洲、中东、非洲和亚太地区设计、制造和销售可注射药物和保健产品的容器和输送系统。它分为两个部分,专有产品和合同制造产品。

Featured Articles

专题文章

  • Get a free copy of the StockNews.com research report on West Pharmaceutical Services (WST)
  • 3 Airline Stocks Stuck in a Holding Pattern
  • Roku Stock is Down but Not Out
  • If You're Hungry for Value, Take a Bite on Ruth's Hospitality Grp
  • Is Ford Rolling To A Rebound After Its Q3 Warning
  • Has AMD stock stock fallen too far?
  • 免费获取StockNews.com关于West Pharmtics Services(WST)的研究报告
  • 3家航空公司股票陷入持有格局
  • Roku股票下跌,但并未出局
  • 如果你渴望价值,那就尝尝露丝的好客之道吧
  • 福特在第三季度发出警告后是否正在反弹
  • AMD股票是不是跌得太厉害了?

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating).

想看看还有哪些对冲基金持有WST吗?访问HoldingsChannel.com获取西方制药服务公司(纽约证券交易所代码:WST-GET Rating)的最新13F文件和内幕交易。

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.

接受《西部医药服务报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对West Pharmtics Services和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发